SCHEMBL27010381

SCHEMBL27010381

c1ccc(-c2cccc(-c3c4ccccc4c(-c4cccc5oc6cccc(-c7ccccc7)c6c45)c4ccccc34)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 3/20 0.40
▸ PLA2G4A P47712 3/20 0.40
▸ PLA2G10 O15496 1/20 0.38
▸ GPR84 Q9NQS5 1/20 0.36
▸ EPHX2 P34913 1/20 0.35
▸ PRKDC P78527 2/20 0.35
▸ RAB9A P51151 3/20 0.35
▸ CA1 P00915 2/20 0.35
▸ CA2 P00918 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ GABRP O00591 1/20 0.35
▸ GABRD O14764 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ CA12 O43570 1/20 0.35
▸ TNKS O95271 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ ABCB1 P08183 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ PARP1 P09874 1/20 0.35
▸ ADORA3 P0DMS8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23426579 0.95 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10GPR84EPHX2
SCHEMBL20109977 0.94 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10GPR84EPHX2
SCHEMBL21131660 0.91 PRKDC (0.39) PLA2G2APLA2G4APLA2G10GPR84EPHX2
SCHEMBL20650703 0.91 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10EPHX2PRKDC
SCHEMBL20109945 0.91 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10GPR84EPHX2
SCHEMBL27010345 0.90 CA1 (0.38) PLA2G2APLA2G4AGPR84RAB9ACA1
SCHEMBL20109957 0.90 CA1 (0.40) GPR84RAB9ACA1CA2ALDH1A1
SCHEMBL27010393 0.90 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10EPHX2PRKDC
SCHEMBL23426577 0.89 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10GPR84EPHX2
SCHEMBL22062618 0.88 PLA2G2A (0.44) PLA2G2APLA2G4APLA2G10PRKDCRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE EED, EML4, ESR1 PLA2G2A 3402/4885PLA2G4A 4288/4885PLA2G10 3755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback